Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1970 Sep 26;3(5725):731-4.
doi: 10.1136/bmj.3.5725.731.

Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man

Clinical Trial

Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man

D J Coltart et al. Br Med J. .

Abstract

Plasma propranolol levels associated with reductions in endogenous and exogenous cardiac beta-stimulation were determined in normal people. The levels associated with a given degree of blockade of exercise-induced tachycardia were about three times greater after intravenous administration than after oral administration. This shows that an active metabolite of propranolol is formed only after the drug is taken by mouth. The greatest reduction in the tachycardia of strenuous exercise was associated with plasma levels of 40 ng./ml. with oral administration and 100 ng./ml. with intravenously administered propranolol.The effect on isoprenaline-induced tachycardia following intravenously administered propranolol showed that the dose ratio for isoprenaline was about 30 with plasma levels of 100 ng./ml. and 10 with levels of 10-20 ng./ml. These plasma levels give 100% and 20-30% blockade of exercise-induced tachycardia. These findings suggest that some of the therapeutic effects of propranolol may be unrelated to beta-adrenergic blockade.

PubMed Disclaimer

References

    1. Am J Cardiol. 1966 Sep;18(3):361-5 - PubMed
    1. Clin Pharmacol Ther. 1970 Jan-Feb;11(1):112-20 - PubMed
    1. Br Med J. 1969 Jan 4;1(5635):7-16 - PubMed
    1. Lancet. 1967 Jul 1;2(7505):12-5 - PubMed
    1. Circ Res. 1968 May;22(5):661-77 - PubMed

Publication types

LinkOut - more resources